Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Regulatory News (SAR)

Share Price Information for Sareum (SAR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    1.00 (4.65%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £31.18m
SAR Live PriceLast checked at - London Stock Exchange

Intraday Sareum Share Chart

Total Voting Rights

30 Nov 2007 07:00

Sareum Holdings PLC30 November 2007 30 November 2007 Sareum Holdings plc ("Sareum" or the "Company") Total Voting Rights In accordance with the FSA's Disclosure and Transparency Rules, the Company would like to notify the market of the following: As at the date of this announcement, the Company's issued share capital consistsof 598,697,713 ordinary shares with a nominal value of 0.025p each ("OrdinaryShares"), with voting rights. The Company does not hold any Ordinary Shares inTreasury. Therefore, the total number of Ordinary Shares with voting rights is598,697,713. The above figure of 598,697,713 Ordinary Shares may be used by shareholders inthe Company as the denominator for the calculations by which they will determineif they are required to notify their interest in, or a change in their interestin, the share capital of the Company under the FSA's Disclosure and TransparencyRules. For further information: Sareum Holdings plc01223 497700Tim Mitchell, Chief Executive Officer Buchanan Communications020 7466 5000Tim Anderson/Mary-Jane Johnson Grant Thornton Corporate Finance020 7383 5100Philip Secrett/Colin Aaronson This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Jun 20214:35 pmRNSPrice Monitoring Extension
17th Jun 202111:05 amRNSSecond Price Monitoring Extn
17th Jun 202111:00 amRNSPrice Monitoring Extension
16th Jun 20212:05 pmRNSSecond Price Monitoring Extn
16th Jun 20212:00 pmRNSPrice Monitoring Extension
16th Jun 20219:06 amRNSSecond Price Monitoring Extn
16th Jun 20219:00 amRNSPrice Monitoring Extension
15th Jun 202111:19 amRNSSubscription to raise £1,470,000
14th Jun 20214:40 pmRNSSecond Price Monitoring Extn
14th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20219:05 amRNSSecond Price Monitoring Extn
9th Jun 20219:00 amRNSPrice Monitoring Extension
1st Jun 20212:05 pmRNSSecond Price Monitoring Extn
1st Jun 20212:00 pmRNSPrice Monitoring Extension
1st Jun 202111:06 amRNSSecond Price Monitoring Extn
1st Jun 202111:00 amRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSSubscription to raise £900,000
25th May 20219:05 amRNSSecond Price Monitoring Extn
25th May 20219:00 amRNSPrice Monitoring Extension
25th May 20217:00 amRNSTrading Statement
17th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20217:00 amRNSExercise of Options and Total Voting Rights
5th May 20211:15 pmEQSEdison Investment Research Limited: Sareum Holdings (SAR): Treading the TYK2 trail
5th May 20217:00 amEQSSareum Holdings (SAR): Treading the TYK2 trail
23rd Apr 20217:00 amRNSHalf-year Report
25th Mar 20212:07 pmRNSResearch Update
25th Mar 20217:00 amRNSInterim Results Extension
16th Feb 20217:00 amRNSSareum Notes New UK Government Covid-19 Initiative
1st Feb 20217:00 amRNSSareum to Present at the LSX World Congress 2021
26th Jan 20217:00 amRNSSareum to Participate in the Edison Open House
11th Jan 202111:06 amRNSSecond Price Monitoring Extn
11th Jan 202111:01 amRNSPrice Monitoring Extension
8th Jan 20213:54 pmRNSUpdate re: FLT3+Aurora Kinase Inhibitor Programme
7th Jan 20217:00 amRNSUS Patent Grant for TYK2/JAK1 Anticancer Candidate
22nd Dec 202011:05 amRNSSecond Price Monitoring Extn
22nd Dec 202011:00 amRNSPrice Monitoring Extension
15th Dec 202012:59 pmRNSResult of AGM
15th Dec 20207:00 amRNSAGM Statement
14th Dec 20207:00 amRNSNature article highlights role of TYK2 in Covid-19
3rd Dec 20207:00 amRNSCovid-19 Research Grant Confirmed
19th Nov 20207:00 amRNSNotice of AGM
12th Nov 202012:13 pmRNSUpdate on SRA737 Licensing Agreement
27th Oct 202011:00 amRNSNotification of Grant Award for Covid-19 Research
26th Oct 202011:05 amRNSSecond Price Monitoring Extn
26th Oct 202011:00 amRNSPrice Monitoring Extension
20th Oct 20201:00 pmRNSExercise of Share Options and Director Dealings
13th Oct 20207:01 amRNSFull Year Results Investor Presentation
13th Oct 20207:00 amRNSFinal Results
12th Oct 20204:41 pmRNSSecond Price Monitoring Extn
12th Oct 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.